23 January 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics evaluates the evidence for the role of gut microbiota in irritable bowel syndrome, and its potential influence on therapeutic targets.
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disease with a substantial social
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors